June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Perturbation of photoreceptor optical characteristics in the early stage of subretinal drusenoid deposits development revealed by adaptive optics imaging
Author Affiliations & Notes
  • Sujin Hoshi
    Doheny Eye Institute, Los Angeles, California, United States
    Tsukuba Daigaku Igaku Iryokei, Tsukuba, Ibaraki, Japan
  • Xiaolin Wang
    Doheny Eye Institute, Los Angeles, California, United States
  • Shin Kadomoto
    Doheny Eye Institute, Los Angeles, California, United States
    Kyoto Daigaku Daigakuin Igaku Kenkyuka Igakubu, Kyoto, Kyoto, Japan
  • Ruixue Liu
    Doheny Eye Institute, Los Angeles, California, United States
  • Giulia Corradetti
    Doheny Eye Institute, Los Angeles, California, United States
  • Michael S Ip
    Doheny Eye Institute, Los Angeles, California, United States
    University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • David Sarraf
    Jules Stein Eye Institute, Los Angeles, California, United States
    University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • SriniVas R Sadda
    Doheny Eye Institute, Los Angeles, California, United States
    University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Yuhua Zhang
    Doheny Eye Institute, Los Angeles, California, United States
    University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Sujin Hoshi Nipro, Machida, logic and design, Code C (Consultant/Contractor), Alcon Japan, Code F (Financial Support), 2017-121307, Code P (Patent); Xiaolin Wang None; Shin Kadomoto Canon, Code F (Financial Support); Ruixue Liu None; Giulia Corradetti None; Michael Ip Boehringer Ingelheim, Thrombogenics, Quark, Omeros, Allergan, Amgen, Astellas, Alimera, Code C (Consultant/Contractor), Genentech, Clearside, Biogen, Code F (Financial Support); David Sarraf Amgen, Bayer, Genentech, Iveric Bio, Novartis, Optovue, Topcon, Code C (Consultant/Contractor), Amgen, Boehringer, Genentech, Heidelberg, Optovue, Regeneron, Code F (Financial Support); SriniVas Sadda Amgen, Allergan, Genentech/Roche, Iveric, Oxurion, Novartis, Regeneron, Bayer, 4DMT, Centervue, Heidelberg, Optos, Merck, Apellis, Astellas, Code C (Consultant/Contractor), Nidek, Topcon, Heidelberg, Carl Zeiss Meditec, Optos, Centervue, Code F (Financial Support); Yuhua Zhang None
  • Footnotes
    Support  NIH Grant R01EY024378, W. F. Keck Foundation, Carl Marshal l R eeves & Mildred Almen Reeves Foundation, and Research to Prevent Blindness/Dr. H. James and Carole Free Catalyst Award for In novative Research Approaches for AMD.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 2146. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sujin Hoshi, Xiaolin Wang, Shin Kadomoto, Ruixue Liu, Giulia Corradetti, Michael S Ip, David Sarraf, SriniVas R Sadda, Yuhua Zhang; Perturbation of photoreceptor optical characteristics in the early stage of subretinal drusenoid deposits development revealed by adaptive optics imaging. Invest. Ophthalmol. Vis. Sci. 2023;64(8):2146.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Subretinal drusenoid deposits (SDD) are extracellular lesions in the subretinal space that have been shown to confer and increased risk for progression to late AMD. Although high-resolution adaptive optics scanning laser ophthalmoscopy (AOSLO) have demonstrated impaired cone photoreceptor reflectivity related to SDD progression, early changes in cone optical properties remain incompletely understood. This study evaluates cone reflectivity during the phase in which SDD were not evident or indeterminate on optical coherence tomography (OCT) using AOSLO.

Methods : Six eyes of 4 patients with intermediate AMD and predominantly SDD underwent multimodal imaging including AOSLO 3-4 times over 3.5 years. Individual SDD were identified by multimodal imaging and graded using an OCT-based 3-stage system at each time point. We evaluated the cross-sectional retinal structure and cone reflectivity at the location in which new SDD developed during the course of follow-up by OCT B-scans and AOSLO.

Results : We identified 32 locations where new dot-form SDD developed during the follow-up period. In the prior assessments at these locations, OCT did not show overt or definitive deposits (stage ≥ 1) between the ellipsoid zone and retinal pigment epithelium complex. However, AOSLO revealed that cones manifested reduced reflectivity in 84% of these regions. The mean time for these sites to develop stages 1, 2, and 3 SDD were 8.9, 13.9, and 25.6 months, respectively.

Conclusions : High-resolution adaptive optics confocal imaging allows for the evaluation of cone photoreceptor optical property alterations associated with SDD development at a phase when these lesions are still not evident on OCT. Our study indicates that cones may demonstrate a reduction in reflectivity 8.9 months before SDDs appear, providing new insight into SDD pathogenesis.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Figure 1. Reduction of cone photoreceptor reflectivity at the early development stage of subretinal drusenoid deposits (SDD). Although OCT showed indiscernible extracellular material at the baseline between the EZ and the RPE, AOSLO revealed that cone photoreceptors became hyporeflective. At the 7-month visit, a stage-1 SDD appeared and progressed to stage-3 at the 25-month visit.

Figure 1. Reduction of cone photoreceptor reflectivity at the early development stage of subretinal drusenoid deposits (SDD). Although OCT showed indiscernible extracellular material at the baseline between the EZ and the RPE, AOSLO revealed that cone photoreceptors became hyporeflective. At the 7-month visit, a stage-1 SDD appeared and progressed to stage-3 at the 25-month visit.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×